What would move this position is: a randomised, placebo-controlled trial in a defined population with an objective primary endpoint, a pre-registered protocol, and pharmacovigilance over a clinically meaningful duration
If you are considering switching between peptides, understanding the concentration differences prevents the kind of dosing confusion that happens when people apply one peptide dose chart to a different peptide
Storage: Desiccated, protected from light, stored at 20 C or below
And a lot of this stuff that weve looked at is just very, very substandard.
Because most evidence is still preclinical or anecdotal, symptom tracking is more useful than expecting a fixed timeline
To avoid these issues, implement robust training programs and regular audits of billing practices